Qiagen’s exoRNeasy Serum/Plasma Maxi Kit shows benefits in new study

Qiagen has announced the publication of a new study that shows the benefits offered by its exoRNeasy Serum/Plasma Maxi Kit.

Appearing in the online journal PLoS ONE, the study confirms the reliability and specificity of the kit in extracting RNA from exosomes and other extracellular vesicles that carry genomic information through the body.

It is one of several Qiagen initiatives to develop sample technology solutions for non-invasive liquid biopsies, which are used for molecular tests in cancer and other diseases.

A key advantage of the product is its standardised protocol, developed in partnership with Exosome Diagnostics, which is designed to be a highly sophisticated method for the extraction of RNA from exosomes.

Dr Markus Sprenger-Haussels, senior director and head of Qiagen's sample technologies unit for life sciences, said: "The Qiagen exoRNeasy Maxi Kit provides a faster, more reliable way to isolate RNA from exosomes for research, delivering high-quality results with less labour-intensive sample preparation."